On July 21, 2020, a new report in the journal The Lancet Diabetes and Endocrinology (“EDCs: time to take action” 21 July 2020, Lancet Diabetes & Endocrinology) argues the various types of chemicals, including certain PFAS, may be linked to human health problems typically seen from hormone disruptors, including infertility, diabetes, and impaired brain development. The report’s findings are the result of a review of hundreds of available studies on endocrine disruptors, PFAS, and other chemicals, as well as regulatory policies in Europe and the United States regarding endocrine disruptors.
Hormone disruptors are chemicals in consumer products that are thought to interfere with the function of hormones in the human body, which in turn disrupts various processes in the body. The most widely publicized chemicals believed to be hormone disruptors are bisphenols, which are chemicals used in many plastics and can linings. Very recent studies have drawn links between hormone disruptors and obesity, to endometriosis (abnormal growth of tissue on the outside of the womb), and to polycystic ovary syndrome, a significant cause of infertility.
The new findings published in the Lancet article suggest that PFAS, bisphenols, and certain pesticides may damage semen and could cause brain-related health concerns, such as IQ loss and attention deficit disorder (ADD).
While the results of the article may raise eyebrows and add to the host of recent information raising opposition to PFAS, the lead author is quick to point out that “…further research is needed to more firmly establish cause and effect….” While much of the articles focuses on chemicals that are not PFAS, the suggestion that the authors make will certainly add fuel to the media fire regarding the potential hazards of PFAS, even though very few of the 7,000+ PFAS have even been researched or tested for effects on human health.
CMBG3 Law is following judicial, legislative, administrative, and scientific developments relating to PFAS. More information about the services we can provide, including risk assessments, to ensure your business is ready for any intersection with these substances can be found on our PFAS Litigation page.
Our attorneys have been at the forefront of PFAS issues, including giving presentations as to the future waves of litigation stemming from PFAS issues. For more information, please contact any of our PFAS – Toxic Torts Team: Jessica Deyoe, Suzanne Englot, Alexandra Fraher,or John Gardella.